Normal function · from ai-gene-review (Q96P20, commit 79fe13b38970) · AI-generated, not KB evidence

NLRP3 (cryopyrin) is a cytosolic NLR-family protein of myeloid and other innate immune cells that nucleates the NLRP3 inflammasome, the platform that activates caspase-1 and so drives maturation of interleukin-1 beta and interleukin-18 and gasdermin-D-dependent pyroptosis. It is built from an N-terminal pyrin domain, a central nucleotide-binding NACHT domain and a C-terminal leucine-rich repeat. In the resting state it is held as an autoinhibited, ADP-bound, membrane-binding oligomeric cage - reported as a decamer and as a dodecamer by different groups - with the pyrin domains sequestered inside the leucine-rich-repeat shell. Activation converts the NACHT domain to an ATP-bound conformation and assembles an active disc in which the pyrin domains stack into a filament that nucleates unidirectional polymerisation of the adaptor ASC, which in turn recruits procaspase-1. NLRP3 has no established direct agonist ligand. It responds to an unusually wide range of stimuli - pore-forming toxins, extracellular ATP, crystals such as monosodium urate, silica and alum, cell swelling, and mitochondrial and lysosomal damage - and the prevailing view is that it detects a shared downstream cellular perturbation, with potassium efflux and disassembly of the trans-Golgi network as common intermediates, rather than binding each agonist. Recruitment to the dispersed trans-Golgi network occurs through ionic interaction between a conserved polybasic region and phosphatidylinositol-4-phosphate, after which microtubule-dependent transport concentrates NLRP3, together with the kinase NEK7, as condensates at the pericentriolar material of the microtubule organising centre. Whether this route is obligatory is disputed: low-molecular-weight, non-cage NLRP3 species can drive a slower, trans-Golgi- and MTOC-distal pathway that dominates in human neutrophils, and raising NLRP3 abundance can make potassium-efflux-driven activation independent of both NEK7 and priming. Gain-of-function mutations, mostly in the NACHT-encoding exon 3, cause the cryopyrin-associated periodic syndromes - familial cold autoinflammatory syndrome, Muckle-Wells syndrome and neonatal-onset multisystem inflammatory disease - which respond to interleukin-1 blockade, and NLRP3 activity contributes to gout, atherosclerosis, silicosis and neuroinflammation. A separate, inflammasome-independent role for NLRP3 as a nuclear transcriptional cofactor that binds the Il4 promoter with IRF4 in T helper 2 cells has been reported in mouse but is not independently corroborated.

NLRP3 nucleates the inflammasome that activates caspase-1. Its N-terminal pyrin domains stack into a filament on the activated oligomer, and that filament seeds unidirectional polymerisation of the adaptor ASC, which recruits procaspase-1 and permits proximity-induced autoprocessing. NLRP3 has no catalytic activity of its own in this step: it supplies the geometry.
Through the assembled inflammasome NLRP3 activates procaspase-1, which matures pro-interleukin-1 beta and pro-interleukin-18 and cleaves gasdermin D to execute pyroptosis. This is the physiological output of NLRP3 and the step that CAPS gain-of-function mutations render constitutive.
A conserved polybasic region of NLRP3 binds phosphatidylinositol-4-phosphate on the dispersed trans-Golgi network through ionic interaction, and this is what recruits and concentrates NLRP3 at the membrane scaffold on which it aggregates. It is the one well-established direct binding event in NLRP3 activation, and the reason the protein can respond to structurally unrelated agonists without binding any of them: diverse stimuli converge on trans-Golgi disassembly. Charge neutralisation of the same linker by BTK phosphorylation tunes the interaction.
The central NACHT domain binds and hydrolyses ATP, and the nucleotide state is the conformational switch of the protein: the resting oligomer is ADP-bound with the pyrin domains sequestered, while the active disc holds an ATP-bound NACHT whose subdomains have rotated by about 85 degrees. Nucleotide binding is required for caspase-1 activation and for the constitutive activity of disease-associated mutants, and the ATP-hydrolysis motif is where the clinical inhibitor MCC950 acts.
molecular function: ATP hydrolysis activity · directly involved in: NLRP3 inflammasome complex assembly · locations: cytosol
NLRP3 scaffolds a biomolecular condensate at the pericentriolar material of the microtubule organising centre, into which microtubule-dependent transport delivers both NLRP3 and the licensing kinase NEK7, and within which the inflammasome assembles. Priming, microtubule transport, NEK7 and NLRP3 abundance all converge on making this environment permissive, which sets the activation threshold. This route is important but not obligatory: low-molecular-weight, non-cage NLRP3 species support a slower trans-Golgi- and MTOC-distal pathway that dominates in human neutrophils.
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Familial Cold Autoinflammatory Syndrome causative germline
mechanism: Constitutive NLRP3 inflammasome activation; NLRP3 gain-of-function mutation
subtype: FCAS1
scoped to subtype: FCAS1
Hearing Loss Autosomal Dominant 34 With or Without Inflammation causative germline gain of function
mechanism: NLRP3 Gain-of-Function Variant
Pyoderma Gangrenosum susceptibility
Alzheimer Disease untyped
Genetic Variant
mechanism: Neuroinflammation
Chronic_Obstructive_Pulmonary_Disease untyped
Inflammasome activation contributes to chronic inflammation.
CINCA Syndrome untyped
Causative
mechanism: NLRP3 gain-of-function mutation
variant: NLRP3 NACHT-domain gain-of-function missense substitutions (de novo)
Kawasaki Disease untyped
NLRP3 inflammasome activation leads to IL-1β release and pyroptosis
mechanism: Immune Response Dysregulation
Muckle-Wells Syndrome untyped
Causative
germline gain of function
mechanism: NLRP3 gain-of-function activation
Atrial Fibrillation no genetic record
mechanism: Fibroblast NLRP3 Inflammasome Activation
animal model: Mouse (Mus musculus)
Bacterial meningitis no genetic record
mechanism: Inflammasome Activation and Pyroptosis
Leptospirosis no genetic record
mechanism: NLRP3 inflammasome complex assembly
Majeed Syndrome no genetic record
mechanism: Loss of Lipin-2 Restraint on the NLRP3 Inflammasome
Major Depressive Disorder no genetic record
animal model: Gsdmd, Casp1 and astrocytic Nlrp3 knockout mice under chronic mild stress
Multiple Sclerosis no genetic record
mechanism: Microglial NLRP3 Inflammasome Activation
Mechanism modules · computed from kb/

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.